Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Hypofractionated Radiotherapy for Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating hypofractionated radiotherapy for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: 68 Ga-PSMA for High Risk Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating 68 Ga-PSMA for high-risk prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating androgen deprivation therapy in combination with docetaxel for high-risk prostate cancer in the neoadjuvant setting…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer. [Phase 3]
A Phase 3 trial evaluating prostate-only versus pelvic radiation for N+ prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP [Phase 2]
Phase 2 clinical trial investigating early salvage stereotactic radiotherapy for biochemical failure after radical prostatectomy in prostati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer [Phase 2]
Phase 2 trial update evaluating hypofractionated radiotherapy as primary therapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Streamlined Genetic Testing in Prostate Cancer [NA]
A completed clinical trial evaluating streamlined genetic testing in prostate cancer. Results were posted in December 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial assessing 68Ga-PSMA-11 to enhance diagnosis of primary and metastatic prostate cancer; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant therapy with abiraterone plus androgen deprivation therapy for high-risk prostate cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer [NA]
A clinical trial evaluating a diet and exercise program for weight loss and health improvement in men with low- to low-intermediate-risk pro…
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy. [Phase 4]
Phase 4 trial update for neoadjuvant hormone therapy in advanced prostate cancer undergoing radical prostatectomy has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: ED50 of Intratecal Prilocaine in Ultrasound Fusion Prostate Biopsy [Phase 4]
Phase 4 clinical trial updating the ED50 of intrathecal prilocaine used during ultrasound fusion prostate biopsy.
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating phenelzine sulfate in non-metastatic recurrent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Phase I Trial of 225Ac-J591 in Patients With mCRPC [Phase 1]
Phase I trial evaluating Actinium-225 labeled J591 (225Ac-J591) in metastatic castration-resistant prostate cancer has completed enrollment …
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a vaccine therapy with pembrolizumab for hormone-resistant metastatic prostate cancer completed with pos…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer [Phase 4]
Phase 4 clinical trial update exploring transurethral prostate enucleation in a surveillance protocol for low-risk prostate cancer and relat…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis [Phase 1, Phase 2]
A clinical trial update evaluating 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT imaging in patients with metastatic prostate cancer has phases 1 and…
-
FDA approval · 2022-11-22FDA Approved: DOCIVYX — Original Application (Avyxa Pharma, LLC)
FDA approves DOCIVYX (docetaxel) under an original NDA submitted by Avyxa Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway [Phase 2]
Phase 2 trial evaluating docetaxel and carboplatin in metastatic castration-resistant prostate cancer with BRCA1/2 pathway inactivation; stu…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab and HER2Bi-armed activated T cells for metastatic castration-resistant prostate cancer has completed …
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Can the Prophylactic Administration of Tranexamic Acid Reduce Blood Loss After Robotic-assisted Radical Prostatectomy? [Phase 4]
This Phase 4 trial investigates whether prophylactic tranexamic acid reduces blood loss after robotic-assisted radical prostatectomy.
-
FDA approval · 2022-11-08FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for Erleada (apalutamide) submitted by Janssen Products, LP.
-
FDA approval · 2022-10-28FDA Approved: LEUPROLIDE ACETATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original ANDA for Leuprolide acetate, a generic version of Lupron.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation [Phase 2]
A Phase 2 study evaluating olaparib in combination with abiraterone and prednisone in metastatic hormone-receptor-mutant prostate cancer is …